NTR
Nutrien Ltd
NYSE · Chemicals
$68.61
+0.63 (+0.93%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 34.48B | 35.23B | 27.93B | 24.90B | 24.03B |
| Net Income | 894.69M | 822.83M | 1.78B | 2.14B | 1.94B |
| EPS | — | — | — | — | — |
| Profit Margin | 2.6% | 2.5% | 6.4% | 8.6% | 8.1% |
| Rev Growth | -2.1% | -2.1% | +14.3% | +14.2% | +8.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 7.75B | 7.75B | 7.15B | 6.63B | 6.41B |
| Total Equity | 14.76B | 14.76B | 19.98B | 20.37B | 20.87B |
| D/E Ratio | 0.52 | 0.52 | 0.36 | 0.33 | 0.31 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 3.73B | 3.62B | 2.67B | 2.29B | 2.51B |
| Free Cash Flow | — | — | 1.22B | 1.46B | 1.43B |